Biovie Inc share price logo

Biovie Inc

NASDAQ: BIVI

Small Cap

$1.65

+0.07

(+4.43%)

as on

Biovie Inc Stock Performance

as on May 1, 2026 at 6:59 am IST

  • Day's Low

    $1.56
    $1.65
    downward going graph

    5.45%

    Downside

  • 52 Week's Low

    52 Week's High

    $1.06
    $13.20
    downward going graph

    35.76%

    Downside

    700.00%

    Upside

    downward going graph

Biovie Inc share price movements today

Previous Close
$1.58
Open
$1.56
Volume
466.3K
Day's Low - High
$1.56 - $1.65
52 Week Low - High
$1.06 - $13.20

Biovie Inc Historical Returns

1 Month Return
+ 17.04 %
3 Month Return
+ 38.6 %
1 Year Return
-80.68 %
3 Year Return
-99.8 %
5 Year Return
-99.91 %

Biovie Inc Stock Fundamentals & Key Indicators

Check Biovie Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$11.9M

EPS (TTM)

-3.02

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-18.0M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

-80.74%

Biovie Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Biovie Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
SELL$11.9M-99.91%NA0.00%
BUY$40.2B114.16%129.828.45%
BUY$109.4B93.97%28.132.94%
NA$32.3BNA117.735.37%
BUY$76.7B42.61%17.6431.41%

Stock Returns calculator for Biovie Inc Stock including INR - Dollar returns

The Biovie Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

Biovie Inc investment value today

Current value as on today

₹22,630

Returns

-₹77,370

(-77.37%)

Returns from Biovie Inc Stock

-₹79,829 (-79.83%)

Dollar Impact

₹2,459 (+2.46%)

Analyst Recommendation on Biovie Inc Stock

Based on 6 analysts

SELL

0.00%

Buy

50.00%

Hold

50.00%

Sell

Based on 6 analysts, 50% of analysts recommend a 'SELL' rating for Biovie Inc. Average target price of $12

Biovie Inc Share Price Target

Get share price movements and forecasts by analysts on Biovie Inc.

What analysts predicted

86.25%UPSIDE

Target Price

$12

Current Price

$1.65

Analyzed by

6 Analysts

Target

$12.00

Biovie Inc target price $12, a slight upside of 86.25% compared to current price of $1.65. According to 6 analysts rating.

Biovie Inc Stock’s Investor Sentiment and Interest

Search interest for Biovie Inc Stock has increased by 75% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:75% versus previous 30 day period

Biovie Inc Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
-
-
-
-
-
-
-
-
-
-
Gross Profit
0
0
0
0
0
0
0
0
0
0
Operating Income
-10
-8
-7
-4
-4
-7
-2
-3
-5
-6
EBITDA
-9
-8
-7
-4
-4
-7
-2
-3
-5
-6
Interest Expense
1
0
0
0
0
0
0
0
0
0
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-10
-8
-8
-4
-4
-7
-2
-3
-5
-6
Income Tax Expense
1
0
0
0
-4
-7
-
7
-
-
Net Income
-10
-8
-8
-4
-4
-7
-2
-3
-5
-6
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Biovie Inc Annual Profit & Loss

All numbers in Millions USD

Jun 2016
Jun 2017
Jun 2018
Jun 2019
Jun 2020
Jun 2021
Jun 2022
Jun 2023
Jun 2024
Jun 2025
Total Revenue
-
-
-
-
-
-
-
-
-
-
Gross Profit
0
0
0
0
0
0
0
0
0
0
Operating Income
0
-1
-2
-2
-2
-138
-27
-45
-32
-18
EBITDA
0
-1
-2
-2
-2
-137
-27
-45
-31
-16
Interest Expense
0
0
0
0
4
0
2
4
2
0
Depreciation
-
0
0
0
0
0
0
0
0
0
Income Before Tax
0
-1
-2
-2
-16
-130
-26
-50
-32
-17
Income Tax Expense
0
0
0
0
4
0
-3
4
0
-
Net Income
0
-1
-2
-2
-16
-130
-26
-50
-32
-17
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Biovie Inc Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Net Income
-8
-8
-4
-4
-7
-2
-3
-5
-6
Operating Cash Flow
-5
-5
-4
-3
-8
-1
-5
-3
-4
Investing Cash Flow
-
-
-
-
-
-
-
-
-
Financing Cash Flow
4
15
-2
0
12
-
12,725,941
10
-
Change in Cash
0
10
-6
-3
4
-1
-5
7
-4

Biovie Inc Annual Cash Flow

All numbers in Millions USD

Jun 2017
Jun 2018
Jun 2019
Jun 2020
Jun 2021
Jun 2022
Jun 2023
Jun 2024
Jun 2025
Net Income
-1
-2
-2
-16
-130
-26
-50
-32
-17
Operating Cash Flow
0
0
-2
-1
-10
-18
-40
-27
-19
Investing Cash Flow
-
-
-
-14
-14
-14
-14
14
-
Financing Cash Flow
0
0
2
1
14
33
55
17
12
Change in Cash
0
0
0
0
4
14
0
4
-6

Global Institutional Holdings in Biovie Inc

Funds
Holdings
FMR Inc
0.22%
UBS Group AG
0.04%
Hanson Mcclain Inc
0.03%
Tradewinds Capital Management, LLC
0%
Philadelphia Trust Co
0.99%

Insights on Biovie Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, BIVI stock has moved up by 10.5%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, BIOVIE INC has experienced a drawdown of -99.8%, however Alnylam Pharmaceuticals, Inc. resisted the overall trend and outperformed by 85.4%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Regeneron Pharmaceuticals, Inc. has given 14.6% return, outperforming this stock by 95.3%

About Biovie Inc

BioVie Inc., a clinical-stage biopharmaceutical company, develops drug therapies to treat neurological and neurodegenerative disorders, and advanced liver disease in the United States. The company develops BIV201, that is in phase 2 for the treatment of ascites due to chronic liver cirrhosis. It also develops NE3107 that is in Phase III clinical trial for the treatment of patients with mild to moderate Alzheimer's disease; and in Phase 2 clinical trial to treat Parkinson's disease, as well as for the long COVID program. The company was formerly known as NanoAntibiotics, Inc. and changed its name to BioVie Inc. in July 2016. BioVie Inc. was incorporated in 2013 and is headquartered in Carson City, Nevada.
OrganisationBiovie Inc
Headquarters680 W. Nye Lane, Carson City, NV, United States, 89703
IndustryBiotechnology
CEOMr. Cuong Viet Do M.B.A.
E-voting on sharesClick here to vote

Key Management of Biovie Inc

Name

Title

Ms. Joanne Wendy Kim CPA

CFO, Treasurer & Corporate Secretary

Dr. Joseph M. Palumbo M.D.

Executive VP of R&D and Chief Medical Officer

Mr. Clarence N. Ahlem

Senior Vice President of Operations

Dr. Penelope Markham Ph.D.

Senior Vice President of Liver Disease Program

Ms. Denise Smith

Senior Vice President of Manufacturing & Development

Dr. Christopher L. Reading Ph.D.

Senior Vice President of Alzheimer's Disease Program

Mr. David Morse

Senior VP & Chief Regulatory Officer

Mr. Cuong Viet Do M.B.A.

President, CEO & Director

FAQs

What is Biovie Inc share price today?

Biovie Inc share price today is $1.65 as on at the close of the market. Biovie Inc share today touched a day high of $1.65 and a low of $1.56.

What is the 52 week high and 52 week low for Biovie Inc share?

Biovie Inc share touched a 52 week high of $13.2 on and a 52 week low of $1.06 on . Biovie Inc stock price today i.e. is closed at $1.65,which is 87.50% down from its 52 week high and 55.66% up from its 52 week low.

What is Biovie Inc's market capitalisation today?

Biovie Inc market capitalisation is $0.00T as on .

How to invest in Biovie Inc Stock (BIVI) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Biovie Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Biovie Inc Shares that will get you 0.9091 shares as per Biovie Inc share price of $1.65 per share as on May 1, 2026 at 1:29 am IST.

What is the minimum amount required to buy Biovie Inc Stock (BIVI) from India?

Indian investors can start investing in Biovie Inc (BIVI) shares with as little as ₹94.91 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹949.10 in Biovie Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Biovie Inc share’s latest price of $1.65 as on May 1, 2026 at 1:29 am IST, you will get 6.0606 shares of Biovie Inc. Learn more about fractional shares .

What are the returns that Biovie Inc has given to Indian investors in the last 5 years?

Biovie Inc stock has given -99.91% share price returns and 27.2% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?